Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach
Year: 2018
Type: review
Source: Cancer Immunology Immunotherapy
Institutions: German Cancer Research Center, TUM Klinikum, Deutsches Konsortium für Translationale Krebsforschung, Technical University of Munich, Paul Ehrlich Institut, Helmholtz-Zentrum Dresden-Rossendorf, National Center for Tumor Diseases, Nationales Centrum für Tumorerkrankungen Dresden, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Charité – Universitätsmedizin Berlin, University Hospital Heidelberg, Georg Speyer Haus
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2787121063